TY - JOUR
T1 - TGF-β isoform signaling regulates secondary transition and mesenchymal-induced endocrine development in the embryonic mouse pancreas
AU - Tulachan, Sidhartha S.
AU - Tei, Eri
AU - Hembree, Mark
AU - Crisera, Christopher
AU - Prasadan, Krishna
AU - Koizumi, Masayuki
AU - Shah, Sohail
AU - Guo, Ping
AU - Bottinger, Erwin
AU - Gittes, George K.
N1 - Funding Information:
The authors would like to thank Prof. LM Wakefield for providing DNTβRII transgenic mice and Prof. CV Wright for providing PDX-1 antibody. This study was supported by grants to G.K.G. from NIH (1 R01 DK58400-01 and 1 R01 DK064952-01), JDRF1 (2-1999-636), tobacco fund (19831-066584) and CHP funds (19831-046903).
PY - 2007/5/15
Y1 - 2007/5/15
N2 - Transforming growth factor-beta (TGF-β) superfamily signaling has been implicated in many developmental processes, including pancreatic development. Previous studies are conflicting with regard to an exact role for TGF-β signaling in various aspects of pancreatic organogenesis. Here we have investigated the role of TGF-β isoform signaling in embryonic pancreas differentiation and lineage selection. The TGF-β isoform receptors (RI, RII and ALK1) were localized mainly to both the pancreatic epithelium and mesenchyme at early stages of development, but then with increasing age localized to the pancreatic islets and ducts. To determine the specific role of TGF-β isoforms, we functionally inactivated TGF-β signaling at different points in the signaling cascade. Disruption of TGF-β signaling at the receptor level using mice overexpressing the dominant-negative TGF-β type II receptor showed an increase in endocrine precursors and proliferating endocrine cells, with an abnormal accumulation of endocrine cells around the developing ducts of mid-late stage embryonic pancreas. This pattern suggested that TGF-β isoform signaling may suppress the origination of secondary transition endocrine cells from the ducts. Secondly, TGF-β isoform ligand inhibition with neutralizing antibody in pancreatic organ culture also led to an increase in the number of endocrine-positive cells. Thirdly, hybrid mix-and-match in vitro recombinations of transgenic pancreatic mesenchyme and wild-type epithelium also led to increased endocrine cell differentiation, but with different patterns depending on the directionality of the epithelial-mesenchymal signaling. Together these results suggest that TGF-β signaling is important for restraining the growth and differentiation of pancreatic epithelial cells, particularly away from the endocrine lineage. Inhibition of TGF-β signaling in the embryonic period may thus allow pancreatic epithelial cells to progress towards the endocrine lineage unchecked, particularly as part of the secondary transition of pancreatic endocrine cell development. TGF-β RII in the ducts and islets may normally serve to downregulate the production of beta cells from embryonic ducts.
AB - Transforming growth factor-beta (TGF-β) superfamily signaling has been implicated in many developmental processes, including pancreatic development. Previous studies are conflicting with regard to an exact role for TGF-β signaling in various aspects of pancreatic organogenesis. Here we have investigated the role of TGF-β isoform signaling in embryonic pancreas differentiation and lineage selection. The TGF-β isoform receptors (RI, RII and ALK1) were localized mainly to both the pancreatic epithelium and mesenchyme at early stages of development, but then with increasing age localized to the pancreatic islets and ducts. To determine the specific role of TGF-β isoforms, we functionally inactivated TGF-β signaling at different points in the signaling cascade. Disruption of TGF-β signaling at the receptor level using mice overexpressing the dominant-negative TGF-β type II receptor showed an increase in endocrine precursors and proliferating endocrine cells, with an abnormal accumulation of endocrine cells around the developing ducts of mid-late stage embryonic pancreas. This pattern suggested that TGF-β isoform signaling may suppress the origination of secondary transition endocrine cells from the ducts. Secondly, TGF-β isoform ligand inhibition with neutralizing antibody in pancreatic organ culture also led to an increase in the number of endocrine-positive cells. Thirdly, hybrid mix-and-match in vitro recombinations of transgenic pancreatic mesenchyme and wild-type epithelium also led to increased endocrine cell differentiation, but with different patterns depending on the directionality of the epithelial-mesenchymal signaling. Together these results suggest that TGF-β signaling is important for restraining the growth and differentiation of pancreatic epithelial cells, particularly away from the endocrine lineage. Inhibition of TGF-β signaling in the embryonic period may thus allow pancreatic epithelial cells to progress towards the endocrine lineage unchecked, particularly as part of the secondary transition of pancreatic endocrine cell development. TGF-β RII in the ducts and islets may normally serve to downregulate the production of beta cells from embryonic ducts.
KW - Dominant-negative TGF-β type II receptor
KW - Endocrine and exocrine differentiation
KW - In vitro culture
KW - Pancreas
KW - TGF-β
KW - TGF-β pan-neutralizing antibody
KW - TGF-β receptors
UR - http://www.scopus.com/inward/record.url?scp=34247638529&partnerID=8YFLogxK
U2 - 10.1016/j.ydbio.2007.02.033
DO - 10.1016/j.ydbio.2007.02.033
M3 - Article
C2 - 17418116
AN - SCOPUS:34247638529
SN - 0012-1606
VL - 305
SP - 508
EP - 521
JO - Developmental Biology
JF - Developmental Biology
IS - 2
ER -